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OBJECTIVES The goal of this study was to determine whether racial differences exist in the functional
behavior of conduit vessels.
BACKGROUND Compared with Caucasians, African Americans have a higher prevalence of cardiovascular
disease and its complications, which may be related to reduced nitric oxide (NO)-dependent
and -independent vasodilation of the microvasculature. However, whether a similar impair-
ment is also present at the level of the conductance arteries is unknown.
METHODS To this end, we studied endothelium-dependent (posthyperemia flow-mediated dilation) and
-independent (nitroglycerin) vascular responses of the brachial artery by high-resolution
ultrasound imaging. There were 46 black subjects (23 men and 23 women; age 37  8 years
and 38  9 years, respectively) and 46 white subjects (23 men and 23 women; age 38  11
years and 36  9 years, respectively) in this study.
RESULTS Baseline diameter was similar in blacks and in whites (4.4  0.9 mm and 4.1  0.7 mm,
respectively). Mean reactive hyperemia after cuff deflation was similar in the two groups (793
 653% in black and 852  734% in white subjects, respectively; p  0.5). Flow-mediated
dilation was significantly lower in black compared with white individuals (4.79  3.5% vs.
8.87 4.5%, respectively; p 0.0001). Nitroglycerin-mediated dilation was also significantly
lower in black individuals compared with white individuals (10.99  4.6% vs. 14.98  5.4%,
respectively; p  0.0002).
CONCLUSIONS African Americans show reduced responsiveness of conductance vessels to both endogenous
and exogenous NO compared with Caucasian Americans. These findings expand our
understanding of racial differences in vascular function and suggest a mechanistic explanation
for the increased incidence and severity of cardiovascular disease observed in African
Americans. (J Am Coll Cardiol 2002;40:754–60) © 2002 by the American College of
Cardiology Foundation
Several previous epidemiologic studies have shown that
atherosclerosis and its complications, the leading cause of
death among adults in the U.S., carry significantly higher
morbidity and mortality in African Americans compared
with Caucasian Americans (1–3). These observations may
be partly explained by a considerably higher prevalence,
among African Americans, of risk factors traditionally
associated with atherosclerosis, such as essential hyperten-
sion, diabetes mellitus, and tobacco use (4–6). However,
the pathophysiologic processes underlying this racial predis-
position have not been fully elucidated (7).
Numerous studies have investigated the role of genetic
and environmental factors in the pathogenesis of hyperten-
sion in African Americans, pointing out important racial
differences in renal function, socioeconomic status, and
hemodynamic responses to environmental challenges (8–
10). In particular, an increased cardiovascular reactivity to
stress has been reported in young normotensive blacks and
has been considered to be a contributor to their greater
prevalence of hypertension (11). More recently, research has
focused on potential differences in arterial wall function
between blacks and whites and their impact on vascular
homeostasis (12). Studies conducted in our, and other,
laboratories have demonstrated reduced nitric oxide (NO)-
mediated vasodilation of forearm resistance vessels to men-
tal stress (13) and to endothelium-dependent and
-independent pharmacologic stimuli (14,15), indicating re-
duced vascular smooth muscle relaxation. This diminished
response to vasodilators may result in a decreased pattern of
hemodynamic reactivity leading, in the long term, to in-
creased vascular tone and hypertension. However, because
these phenomena refer to resistance vessels, they may not
account for the increased predisposition of African Ameri-
cans for developing atherosclerosis in large conductance
arteries.
The purpose of the present investigation, therefore, was
to determine whether racial differences exist in the func-
tional behavior of conduit vessels. Because of the well-
known association between atherosclerosis and impaired
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vascular responses to endothelium-dependent stimuli, we
hypothesized that African Americans would have reduced
endothelial vasodilator function.
METHODS
Study subjects. Ninety-two healthy subjects took part in
the study. The study sample size was prospectively calcu-
lated to detect a 50% relative (or 2.1% absolute) differ-
ence in flow-mediated dilation (FMD) of the brachial artery
(BA) between African Americans and Caucasians, with
80% power and an alpha of 0.05, assuming that the variance
of BA dilation in blacks and whites is similar to that
reported by Vogel et al. (16) in middle-aged men (i.e.,
[3.6]2). The participants’ characteristics and lipid profile are
reported in Table 1. Before admission, subjects of each
group were screened by clinical history, physical examina-
tion, electrocardiography, chest X-ray, and routine chemical
analyses. Exclusion criteria were smoking, history, or evi-
dence of hypertension (blood pressure 140/90 mm Hg),
hypercholesterolemia (total plasma cholesterol 200 mg/
dl), diabetes mellitus, cardiac disease, peripheral vascular
disease, coagulopathy, or any other disease predisposing
them to vasculitis or Raynaud’s phenomenon.
The study protocol was approved by the National Heart,
Lung, and Blood Institute’s (NHBLI) Institutional Review
Board (NIH protocol # 98-H-0112), and all participants
gave written informed consent for all procedures. All pro-
cedures followed were in accordance with the NHLBI
Institutional Guidelines.
Protocol. All studies were performed in the morning in a
quiet room with a temperature of approximately 22°C.
Participants were asked to refrain from drinking alcohol or
beverages containing caffeine for at least 24 h before the
study. Endothelium-dependent and -independent vasodila-
tor function was assessed as previously described (17).
Briefly, subjects lay supine on a bed and were allowed to rest
for at least 10 min. Then, the left BA was visualized, 2 to 15
cm proximal to the antecubital fossa, using a high-resolution
ultrasound (Hewlett Packard Sonos 5500 [Andover, Massa-
chusetts] with a 7.5 MHz linear array transducer).
After baseline images and flow measurements were ob-
tained, a pressure cuff applied on the forearm was inflated at
200 to 250 mm Hg for 5 min. Blood flow was measured
during the 15 s after cuff deflation, and arterial image
acquisitions for diameter measurements were performed
between 60 s and 90 s after cuff deflation.
After at least 15 min of rest, new baseline images and flow
measurements were obtained, and 0.4 mg of nitroglycerin
(NTG) spray were given sublingually to assess endothelium-
independent vasomotor responsiveness. Blood flow and images
for arterial diameter were recorded after 3 min.
Arterial diameter was measured from the anterior to the
posterior “m” line (the interface between media and adven-
titia) at end-diastole, incident with the R-wave on the
electrocardiogram. Images were analyzed by an investigator
blinded to image sequence and subjects’ clinical data.
Statistical analysis. All group data are reported as mean 
SEM. Group differences were analyzed by unpaired Student
t test. Correlations between variables were calculated using
Pearson’s coefficient. Univariate and multivariate analyses of
associations were assessed using standard linear regression
techniques. Multivariate regression models for the variables
FMD and nitroglycerin-mediated dilation (NMD) always
included race and other relevant covariates of interest (stated
specifically in each case) as main effects along with race-by-
covariate interactions. In the analyses that included only one
continuous covariate other than race, a standard analysis of
covariance (ANCOVA) with an interaction term was used.
If the interactions with race were significant, the p values
associated with model main effects (including that for race)
were deemed uninterpretable, and the analyses were strati-
fied and reported by race. All calculated p values are two-tailed,
and a value of p  0.05 was considered to indicate statistical
significance. Statistical analyses were performed using SigmaS-
tat 2.03 (SPSS Inc., Chicago, Illinois).
RESULTS
Effects of race on BA diameter and on FMD. Baseline
BA diameter before hyperemia was larger in African Amer-
Abbreviations and Acronyms
ANCOVA  analysis of covariance
BA  brachial artery
BMI  body mass index
cGMP  cyclic guanosine-monophosphate
FMD  flow-mediated dilation
NHBLI  National Heart, Lung, and Blood Institute
NMD  nitroglycerin-mediated dilation
NO  nitric oxide
NTG  nitroglycerin
SBP  systolic blood pressure
sGC  soluble guanylyl cyclase
VSMC  vascular smooth muscle cell
Table 1. Clinical Characteristics of Study Population
Parameters
Black
Subjects
White
Subjects
p
Value
Gender (male/female) 23/23 23/23
Age (yrs) 37  1.7 37  2.1 0.91
BMI (kg/m2) 28.1  0.9 24.4  0.6 0.001
Glucose (mg/dl) 93  1.7 92  2.2 0.89
Total cholesterol (mg/dl) 163  4.6 165  4.9 0.59
LDL cholesterol (mg/dl) 100  5.5 97  4.2 0.53
HDL cholesterol (mg/dl) 47  3 51  3.8 0.22
Triglycerides (mg/dl) 74  9.2 92  10 0.06
Homocysteine (mol/l) 8.3  0.4 8  0.4 0.51
Systolic BP (mm Hg) 123  2 117  2 0.02
Diastolic BP (mm Hg) 70  1 68  1 0.6
Mean BP (mm Hg) 87  2 85  2 0.16
Heart rate (beats/min) 67  3 67  2 0.9
BMI  body mass index; BP  blood pressure; HDL  high-density lipoprotein;
LDL  low-density lipoprotein.
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icans compared with Caucasians (4.4  0.2 mm vs. 4.1 
0.1 mm, respectively), but this difference did not reach
statistical significance (p  0.102). Mean reactive hyper-
emia after cuff deflation was similar in the two groups (793
 135% in black and 852  153% in white subjects,
respectively; p  0.5). Flow-mediated dilation was signifi-
cantly higher in white compared with black individuals
(8.87 1% vs. 4.79 0.7%, respectively; p 0.0001) (Fig.
1, left panel). Similarly, NMD was significantly higher in
white compared with black individuals (14.98  1.1% vs.
10.99  1%, respectively; p  0.0002) (Fig. 1, right panel).
To evaluate if the relationship between FMD and NMD
varies with race, we performed an ANCOVA for FMD,
with race, NMD and race  NMD as covariates. The
interaction term (race  NMD) was significant (p 
0.016), meaning that the relation of FMD with NMD does,
in fact, vary with race. Consequently, in univariate analysis,
FMD was significantly associated with NMD in Caucasian
Americans (r  0.547; p  0.0001), whereas no correlation
was observed between FMD and NMD in African Amer-
icans (r  0.09; p  0.515).
Baseline diameter was a significant predictor of FMD and
NMD in all patients taken together (p  0.01 and p 
0.001, respectively). To determine a possible contribution of
race in the relationship between baseline diameter and
FMD, and between baseline diameter and NMD, we
performed ANCOVA analyses for FMD and NMD, with
race, baseline diameter and race  baseline diameter as
covariates. The interaction term (race  baseline diameter)
was not significant in the model for FMD (p  0.113) nor
NMD (p  0.09). In a subset analysis, FMD showed only
a weak inverse correlation with baseline diameter in Cau-
casian Americans (r  0.373, p  0.016) and no signif-
icant correlation with baseline diameter in African Ameri-
cans (r  0.193, p  0.197). In contrast, NMD was
significantly and inversely correlated with baseline diameter
in both blacks (r  0.511, p  0.0003) and whites (r 
0.591, p  0.0001).
Race effects on FMD and NMD persisted (p  0.001
and p  0.009, respectively) over and above diameter
difference at baseline between African Americans and Cau-
casian Americans in a multivariate model including race,
baseline diameter, body mass index (BMI), and systolic
blood pressure (SBP).
In African Americans, BMI was significantly higher
compared with Caucasians (Table 1). Therefore, to estimate
a possible contribution of BMI to FMD and NMD, a
multiple linear regression model using race and BMI as
independent variables was applied. Flow-mediated dilation
could be significantly predicted by race but not by BMI
(p  0.0001 and p  0.8118, respectively), whereas NMD
was significantly predicted by race and BMI (p  0.0121
and p 0.0166, respectively). However, the contribution of
BMI to FMD and NMD did not differ between African
Americans and Caucasians, as can be seen in the scatter
regression plots (Fig. 2). To formally test for a possible effect
of race in the relationships between BMI and FMD, and
BMI and NMD, we performed ANCOVA analyses for FMD
and NMD, with race, BMI and raceBMI as covariates. The
interaction term (race  BMI) was not significant in the
model for FMD (p  0.898) nor NMD (p  0.943).
African Americans showed a slightly, albeit statistically
significant, higher SBP compared with whites (Table 1). On
correlation analyses, baseline diameter was significantly
correlated with SBP in blacks but not in whites (r  0.43,
p  0.003 and r  0.27, p  0.07, respectively). On
multivariate linear analysis, SBP was not a significant
predictor of FMD or NMD whether all patients were
analyzed together (p  0.116 and p  0.201, respectively)
or whether the analysis was performed separately for each of
the racial subgroups (p 0.302 and p 0.523, respectively,
in African Americans and p  0.901 and p  0.91,
Figure 1. Bar graph showing a comparison of flow-mediated dilation (left panel) and nitroglycerin (NTG)-mediated dilation (right panel) between African
Americans (black bars) and whites (hatched bars). The p values represent the results of unpaired Student t test. Values represent mean  SEM.
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respectively, in Caucasians). To formally evaluate potential
interactions of race in the relations between SBP and FMD,
and SBP and NMD, ANCOVA analyses for FMD and
NMD, with race, SBP and race  SBP as covariates were
performed. The interaction term (race  SBP) was not
significant in the model for FMD (p  0.631) nor NMD
(p  0.716).
On multivariate analysis no association was found be-
tween either FMD or NMD and age, total plasma choles-
terol and plasma homocysteine levels in both African
Americans and whites (p  NS for all variables).
Effects of gender and race on BA diameter and on
FMD. Before hyperemia baseline BA diameter was similar
between African American and Caucasian women (3.7 
0.1 mm vs. 3.6  0.1 mm, respectively; p  0.24). Mean
reactive hyperemia after cuff deflation was 663  72% in
black women and 784 119% in white women, respectively
(p  0.39). Flow-mediated dilation was significantly lower
in black women compared with white women (5.1  0.7%
vs. 9.1  1%, respectively; p  0.0295). Similarly, African
American women showed significantly reduced NMD com-
pared with Caucasian women (12.07  1% vs. 17.07 
1.1%, respectively; p  0.002) (Fig. 3).
Baseline BA diameter was slightly, but significantly,
lower in Caucasian men compared with African American
men (4.7 0.1 mm vs. 5 0.1 mm, respectively; p 0.03).
Mean reactive hyperemia after cuff deflation was 923 
176% in black men and 645  70% in white men,
respectively (p  0.15). Flow-mediated dilation was signif-
icantly lower in black men compared with white men (4.4
Figure 2. Scatterplot showing the relationship between flow-mediated dilation (FMD) (left panel) and nitroglycerin-mediated dilation (NMD) (right
panel) in African Americans (closed circles and lower regression lines) and whites (open circles and upper regression lines). BMI  body mass index.
Figure 3. Bar graph showing a comparison of flow-mediated dilation (left panel) and nitroglycerin-mediated dilation (right panel) between African
American men and women (black bars) and white men and women (hatched bars). The p values represent the results of unpaired Student t test. Values
represent mean  SEM.
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0.7% vs. 8.7  0.8%, respectively; p  0.00075). Similarly,
African-American men showed significantly reduced NMD
compared with Caucasian men (9.9  1% vs. 12.9  1.1%,
respectively; p  0.026) (Fig. 3).
DISCUSSION
The results of this study show that African Americans have
significantly reduced FMD and NMD of the BA compared
with Caucasian Americans. These blunted responses sug-
gest a diminished response to NO-induced vasorelaxation
because both stimuli act through either an increase in the
endogenous release of NO caused by shear stress (FMD)
(18) or direct formation of NO (NTG) (19). Specifically,
the attenuation of the response to NTG seems to indicate
that the blunted response to NO is related to an
endothelium-independent mechanism. These findings are
in keeping with those of previous investigations from our,
and other, laboratories showing decreased endothelium-
dependent and -independent blood flow responses in the
forearm circulation of healthy black subjects (13–15). It is,
therefore, reasonable to speculate that similar pathophysio-
logic differences may be operative in both the macro- and
microcirculation of African Americans compared with Cau-
casian subjects.
Mechanisms of decreased FMD and NMD in African
Americans. Various mechanisms might explain the de-
creased NO-dependent vasorelaxation observed in black
subjects. First, a generalized defect in vasodilator function
might be present in the vasculature of African Americans.
However, in a previous investigation (15), we have shown
that peak hyperemic vasodilator response to forearm isch-
emia, which is not primarily dependent on NO availability,
is similar between blacks and whites, suggesting that the
blunted dilator response is unlikely related to nonspecific
abnormalities in vascular reactivity. Second, the impaired
NO-dependent relaxation could be related to a reduced
bioavailability of NO/NTG to the smooth muscle cells due
to structural changes in the arterial wall, as described in the
microcirculation of normotensive blacks (20,21), or to an
increased destruction of NO by overproduction of oxygen-
derived free radicals in the vessel wall (22). However, these
mechanisms seem unlikely because NTG is converted to
NO within the smooth muscle cells (23). Further, essential
hypertensive patients, who commonly have vascular wall
hypertrophy, show preserved vasodilator response to sys-
temic nitrates (24). A third and more likely explanation for
the impaired dilating effect of NO is a selective defect of
vascular smooth muscle cell (VSMC) function, in particular
of the soluble guanylate cyclase (sGC)/cyclic guanosine
monophosphate (cGMP) signaling system. A defect in one
or more of the steps of this pathway might impair cGMP-
mediated vasorelaxation and, thus, be responsible for the
attenuation of vasodilator function observed in normoten-
sive African Americans.
Our results differ from those recently reported by Gokce
et al. (25), showing that FMD is similar, and NMD higher,
in African Americans compared with whites. Participants in
the Gokce et al. (25) study, however, were, on average,
between seven and nine years older than our subjects and
included hypertensive patients, a number of whom were
treated with aspirin, antihypertensive medications and lipid-
lowering drugs. It is possible that older age and drugs effects
may have affected vascular function and responses. In
support of this hypothesis is the finding that, when com-
parison between blacks and whites was performed after
excluding subjects on pharmacologic treatment, the differ-
ence in NMD response lost its statistical significance (25).
In partial contrast with our findings, impairment in FMD
with preserved response to sublingual NTG administration
has recently been reported in young, healthy African Amer-
icans by Perregaux et al. (26). Two important differences in
the study methodology may explain this discrepancy. First,
subjects included in the study by Perregaux et al. (26) were,
on average, seven years younger than those in our investi-
gation. It is possible that decreased FMD precedes the
reduction in NMD among African Americans, thus provid-
ing an explanation for the different results. Second, in the
study of Perregaux et al. (26), only 11 subjects in each group
(50% of those included in the study) underwent assess-
ment of NMD. Thus, it is possible that the study was
underpowered to detect racial differences in NMD. Further,
the baseline BA diameter of the 11 black subjects in whom
NMD was assessed was substantially smaller than that
measured in the 11 white subjects who underwent similar
studies (3.58  0.29 mm vs. 3.94  0.24 mm, respectively).
In fact, although the absolute BA diameter during reactive
hyperemia was remarkably similar between the black and
the white subjects who underwent FMD assessment (3.84
 0.2 mm vs. 3.85  0.1 mm, respectively), the absolute
BA diameter during NMD was substantially smaller in
black compared with white subjects (4.26 0.3 mm vs. 4.68
 0.22 mm, respectively). It is possible that differences in
baseline BA diameter in the subsets of subjects undergoing
FMD and NMD explain the observed results. In our study
all subjects underwent assessment of FMD and NMD, thus
allowing equal power to detect racial differences in
endothelium-dependent and -independent vasodilation.
Moreover, the number of subjects undergoing NMD was
more than four times greater in our study than in the study
by Perregaux et al. (92 vs. 22, respectively). These differ-
ences in protocol design and methodology between the
studies may account for the apparent discrepancy with
regard to racial differences in NMD.
In our study African Americans had higher baseline
diameter compared with whites. Despite the nonstatistical
significance of this difference, we wanted to ascertain a
possible contribution of this variable to FMD and NMD.
To this aim, we performed a multivariate analysis with race,
baseline diameter, BMI, and SBP as independent variables.
A highly significant contribution of race on FMD and
NMD persisted over and above differences in diameter at
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baseline. Therefore, the presence of different baseline diam-
eter does not weaken the contribution of racial factors to the
reduced vascular reactivity observed in our subjects.
A recent study by Tounian et al. (27) reported reduced
FMD and NMD in obese children compared with healthy
controls. Because our groups differed with respect to BMI,
we were concerned about a possible contribution of this
variable to FMD and NMD. Therefore, we applied a
multiple regression model using race and BMI as indepen-
dent variables. In this model black race was the only
significant predictor of decreased FMD. Nitroglycerin-
mediated dilation could be significantly predicted by both
race and BMI, although the contribution of BMI to NMD
was similar in African Americans and Caucasian. Thus,
despite the baseline differences in BMI between the two
groups, this variable does not explain the racial differences in
vascular reactivity observed in our study.
Gender, racial factors, and NO-dependent dilation.
Consistent with the results in the overall study population,
both black men and black women showed reduced
endothelium-dependent and -independent vasorelaxation
compared with their white counterparts. These observations
indicate that the role played by racial factors in the blunted
NO-induced vasodilator response in African Americans is
independent of gender.
Decreased NO/cGMP activity and atherosclerosis.
Vascular smooth muscle cell proliferation is an important
component of vessel wall remodeling during atherosclerosis
formation (28). In vitro studies indicate that the NO/
cGMP system inhibits VSMC proliferation, suggesting a
potential link between impaired NO/cGMP activity and
atherogenesis (29). Because the same signaling cascades
regulating VSMC contractile state are involved in VSMC
proliferation, it is possible that a defect in the NO/cGMP
system leads to an impairment of both the vascular relax-
ation and the proliferation control mechanisms in African
Americans. Our data are in agreement with two recent
studies showing impaired endothelium-dependent and
-independent responses of the BA of asymptomatic subjects
with risk factors for atherosclerosis (30) and in patients with
coronary heart disease (31), respectively. Taken together,
these findings support the hypothesis that a dysfunction of
VSMC may be a previously unrecognized feature in the
pathophysiology of atherosclerosis.
CONCLUSIONS
Our study indicates that healthy African Americans have
reduced vascular responsiveness of conduit vessels to both
endothelium-dependent and -independent stimuli com-
pared with Caucasian Americans. This difference may be
related to an abnormality of the sGC/cGMP signaling
system in vascular smooth muscle cells and might play a role
in the increased prevalence of atherosclerosis in African
Americans.
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